Molecular replacement study on form-B monoclinic crystal of insulin

The form-B monodinic insulin crystal was obtained from the sodium citrate buffer with 1% zinc chloride, keeping phenolic content between 0.76% and 1.25%. Its space group is P21, cell constants are: a = 4.924nm, b=6.094nm, c=4.818nm, β=95.8°. There are 6 insulin molecules which form a hexamer. The initial phase was obtained by using rotation function program of X-PLOR program package and molecular packing program of our laboratory. The molecular model was chosen from 4 zinc bovine insulin hexamer. After the preliminary refinement by using the rnacromolecular rigid body refinement technique, the molecular model was further refined and adjusted by using the energy-minimizing stereochemically restrained least-squared refinement on the difference Fourier maps. The finial R-factor is 214% at 0.3nm resolution, the r.m.s. deviations from standard bond length and bond angle are 0.0022nm and 4.7°, respectively.     

胰岛素单斜晶体(B型)结构的分子置换法研究

在含有ZnCl₂的柠檬酸缓冲体系中,保持苯酚浓度在0.76％～1.25％之间,获得了胰岛素单斜晶体(B型),空间群为P2₁,晶胞参数为:a=4.924 nm,b=6.094nm,c=4.818nm,β=95.8°,每个独立区包含有由6个胰岛素分子构成的1个六聚体。以四锌牛胰岛素六聚体作模型,用X-PLOR软件中的旋转函数程序和本实验室的分子密堆积程序,获得了胰岛素单斜晶体(B型)结构的初始相位。借助生物大分子刚体精化技术对模型进行了初步精化,用能量极小化的立体化学制约的最小二乘精化技术并辅以差值Fourier图人工分析对模型进行了调整和精化。最终R因子为22.4％,键长和键角与标准键长和键角的偏差分别为0.0022nm和4.7°。